Phase 1 Study Testing the Combination of Aflibercept and Capecitabine in Metastatic Digestive and Breast Cancers (MOMENTUM1)
Phase of Trial: Phase I
Latest Information Update: 02 Feb 2018
At a glance
- Drugs Aflibercept (Primary) ; Capecitabine (Primary)
- Indications Biliary cancer; Breast cancer; Colorectal cancer; Gastrointestinal cancer; Oesophageal cancer; Pancreatic cancer
- Focus Adverse reactions
- Acronyms MOMENTUM1
- 12 Jan 2017 Status changed from active, no longer recruiting to completed.
- 04 Mar 2016 Planned End Date changed from 1 Dec 2015 to 1 Dec 2016 as reported by ClinicalTrials.gov record.
- 04 Mar 2016 Planned primary completion date changed from 1 Oct 2015 to 1 Oct 2016 as reported by ClinicalTrials.gov record.